glp 1 receptor agonists effects on cardiovascular risk reduction GLP-1 in Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies 367. GLP-1 Agonists: Clinical Implementation
Description
Track protein intake for at least the first three months until high-protein habits are automatic

Inhibit glucagon release Figure 1

Therapy with GLP-1RA should therefore start with low doses that can be uptitrated ( GLP-1RA has been placed prominently in the international recommendations for the treatment of T2D as the first injectable agent before insulin due to the advantageous outcomes in cardiovascular safety studies that demonstrated a reduction of the combined cardiovascular endpoint three-component major adverse cardiovascular event (MACE-3

Understanding the tradeoffs helps you make an informed choice

10.1210/jc.2009-0921 34 Hauge-EvansA

Broccoli Soup with Nutritional Yeast Flakes Serves 4 Ingredients: 2 broccoli heads and stems roughly chopped 2 TBSP coconut oil-melted 2 cups homemade vegetable stock 2 garlic cloves 1 onion chopped 2 sticks celery copped Sea Salt to taste 1 handful fresh mint 1 handful fresh parsley cup coconut milk (optional) Handful of slithered almonds to garnish Method: In a large heavy bottom saucepan place coconut oil, heat and add garlic and onion and cook until translucent Throw in chopped celery and cook through Add the broccoli including stems and pour in stock Bring to boil, reduce heat and add seasoning and herbs Simmer for 15 minutes and stir in coconut milk Place in blender then blend together until smooth and return to pan if it needs reheating Garnish with slithered almonds
